PE(14:1(9Z)/24:1(15Z))

Metabolite details

Identifier

QHFLHJLJIVRZEW-KBELHWENSA-N

InChI Key

QHFLHJLJIVRZEW-KBELHWENSA-N

IUPAC name

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-tetracos-15-enoate

Preferred name

PE(14:1(9Z)/24:1(15Z))

INN name

—

Synonym

—

ChEBI

CHEBI:170692

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Industrial by-products as a novel circular source of biocompatible extracellular vesicles
• <i>Pseudomonas</i> sp. Strain 273 Incorporates Organofluorine into the Lipid Bilayer during Growth with Fluorinated Alkanes
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Brewer_Spend_Yeast_vs_Whey
• Decane_vs_Difluorodecane
• Control_12h_vs_Toxocara canis_12h
• G1_Ctrl_vs_G2_Ab
• BSA_Control_vs_AA